Skip to main content

Market Overview

Why Second Sight Medical's Stock Is Trading Higher Today

Share:
Why Second Sight Medical's Stock Is Trading Higher Today

Second Sight Medical Products (NASDAQ: EYES) shares are trading higher Tuesday after the company announced that it was issued a U.S. Patent for the uses of eye-tracking in a visual prosthesis.

Second Sight Medical Products develops, manufactures and markets implantable prosthetic devices, to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP.

Second Sight Medical Products shares traded up 18.17% to $2.47. The stock has a 52-week high of $6.40 and a 52-week low of 69 cents.

 

Related Articles (EYES)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Legal Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com